Watch ELVN. Know when insiders buy.
One email the day a filing lands. Free.
ELVN
Enliven Therapeutics, Inc.
41.49
−0.03 −0.07%
USD · Oct 26, 07:41 p.m. ET
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
33
FLAG · insiders 25, shorts 40
Insiders, 90 days
−$1.6M
net selling · 0 buys, 9 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3BP/E —DIV YIELD —FCF YIELD -2.21%REV TTM —NET INCOME −$105.9MNET CASH —52W 15.14 – 61.15NEXT EARNINGS Nov 11 EST.SEC XBRL · TTM TO Invalid Date
Insider trading
−$1.6M
Net, 90 days
0 / 9
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 19 | Oct 21 | Hohl Benjamin · CHIEF FINANCIAL OFFICER | Sell | 6,018 | $38.48 | $232K |
| Oct 19 | Oct 21 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Sell | 5,000 | $38.47 | $192K |
| Oct 1 | Oct 5 | Garland J. Scott · Director | Sell | 13,000 | $46.67 | $607K |
| Sep 17 | Sep 21 | Hohl Benjamin · CHIEF FINANCIAL OFFICER | Sell | 289 | $51.49 | $15K |
| Sep 17 | Sep 21 | Hohl Benjamin · CHIEF FINANCIAL OFFICER | Sell | 2,194 | $50.72 | $111K |
| Sep 17 | Sep 21 | Hohl Benjamin · CHIEF FINANCIAL OFFICER | Sell | 3,535 | $50.03 | $177K |
| Sep 17 | Sep 21 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Sell | 240 | $51.48 | $12K |
| Sep 17 | Sep 21 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Sell | 1,844 | $50.71 | $94K |
| Sep 17 | Sep 21 | Collins Helen Louise · CHIEF MEDICAL OFFICER | Sell | 2,916 | $50.03 | $146K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.